While PSMA-PET gains popularity as the primary diagnostic modality for PCa, it is also brought to attention that a pre-imaging biopsy may compromise the performance of PSMA-PET/CT or PSMA-PET/MR, in a similar way to that of MRI. The gene discussed is FOLH1; the disease is posterior cortical atrophy.